Valiant Other Liab vs Other Stockholder Equity Analysis

VALIANTORG

322.90 3.60 1.10%

Valiant Organics financial indicator trend analysis is much more than just breaking down Valiant Organics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Valiant Organics is a good investment. Please check the relationship between Valiant Organics Other Liab and its Other Stockholder Equity accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valiant Organics Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Other Liab vs Other Stockholder Equity

Other Liab vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Valiant Organics Other Liab account and Other Stockholder Equity. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Valiant Organics' Other Liab and Other Stockholder Equity is -0.47. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Valiant Organics Limited, assuming nothing else is changed. The correlation between historical values of Valiant Organics' Other Liab and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Valiant Organics Limited are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Other Liab i.e., Valiant Organics' Other Liab and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-0.47

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Other Liab

Other Stockholder Equity

Most indicators from Valiant Organics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Valiant Organics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valiant Organics Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Selling General Administrative is likely to drop to about 52 M in 2024. Tax Provision is likely to gain to about (2.8 M) in 2024

	2021	2022	2023	2024 (projected)
Interest Expense	64.8M	107.9M	163.4M	171.6M
Depreciation And Amortization	296.2M	291.9M	349.2M	366.7M

Interest Expense Depreciation And Amortization

Valiant Organics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Short Term Investments	Other Liab
Total Assets		0.98	0.71	1.0	1.0	1.0	0.81	0.98	1.0	0.97	0.49	1.0	0.12	0.68	0.98	-0.57	0.89	0.99	0.94	-0.38	1.0	0.99	0.96	0.98	0.68	0.94
Short Long Term Debt Total	0.98		0.71	0.98	0.96	0.97	0.79	1.0	0.97	0.91	0.62	0.96	0.04	0.76	0.98	-0.46	0.92	0.97	0.87	-0.49	0.99	0.99	0.99	0.96	0.73	0.93
Other Current Liab	0.71	0.71		0.68	0.71	0.74	0.93	0.7	0.7	0.59	0.58	0.72	-0.15	0.69	0.63	-0.13	0.8	0.65	0.61	-0.48	0.71	0.68	0.65	0.81	0.63	0.74
Total Current Liabilities	1.0	0.98	0.68		0.99	0.99	0.78	0.98	1.0	0.97	0.49	0.99	0.14	0.67	0.98	-0.59	0.87	0.99	0.94	-0.38	1.0	0.98	0.98	0.98	0.67	0.93
Total Stockholder Equity	1.0	0.96	0.71	0.99		1.0	0.81	0.97	1.0	0.98	0.45	1.0	0.13	0.64	0.97	-0.6	0.88	0.99	0.96	-0.34	0.99	0.98	0.95	0.98	0.65	0.93
Property Plant And Equipment Net	1.0	0.97	0.74	0.99	1.0		0.83	0.98	1.0	0.96	0.48	1.0	0.13	0.68	0.97	-0.56	0.89	0.99	0.94	-0.38	0.99	0.98	0.96	0.98	0.68	0.93
Current Deferred Revenue	0.81	0.79	0.93	0.78	0.81	0.83		0.78	0.8	0.72	0.63	0.81	-0.04	0.72	0.75	-0.18	0.9	0.76	0.7	-0.42	0.8	0.79	0.73	0.85	0.66	0.84
Net Debt	0.98	1.0	0.7	0.98	0.97	0.98	0.78		0.97	0.92	0.59	0.97	0.07	0.75	0.98	-0.48	0.92	0.98	0.89	-0.48	0.99	0.99	0.99	0.96	0.72	0.94
Retained Earnings	1.0	0.97	0.7	1.0	1.0	1.0	0.8	0.97		0.97	0.45	1.0	0.17	0.66	0.97	-0.59	0.87	0.99	0.95	-0.37	0.99	0.98	0.96	0.98	0.68	0.93
Accounts Payable	0.97	0.91	0.59	0.97	0.98	0.96	0.72	0.92	0.97		0.33	0.98	0.19	0.51	0.94	-0.71	0.79	0.96	0.98	-0.17	0.96	0.93	0.9	0.92	0.53	0.88
Cash	0.49	0.62	0.58	0.49	0.45	0.48	0.63	0.59	0.45	0.33		0.43	-0.46	0.8	0.56	0.17	0.69	0.46	0.27	-0.6	0.52	0.58	0.58	0.55	0.55	0.54
Non Current Assets Total	1.0	0.96	0.72	0.99	1.0	1.0	0.81	0.97	1.0	0.98	0.43		0.15	0.63	0.96	-0.62	0.87	0.98	0.96	-0.32	0.99	0.97	0.95	0.98	0.64	0.92
Non Currrent Assets Other	0.12	0.04	-0.15	0.14	0.13	0.13	-0.04	0.07	0.17	0.19	-0.46	0.15		-0.05	0.05	-0.17	-0.04	0.18	0.16	-0.08	0.1	0.07	0.12	0.1	0.15	0.1
Cash And Short Term Investments	0.68	0.76	0.69	0.67	0.64	0.68	0.72	0.75	0.66	0.51	0.8	0.63	-0.05		0.71	0.15	0.81	0.7	0.4	-0.89	0.69	0.76	0.75	0.71	0.94	0.74
Net Receivables	0.98	0.98	0.63	0.98	0.97	0.97	0.75	0.98	0.97	0.94	0.56	0.96	0.05	0.71		-0.52	0.9	0.98	0.89	-0.41	0.99	1.0	0.97	0.94	0.69	0.94
Common Stock Shares Outstanding	-0.57	-0.46	-0.13	-0.59	-0.6	-0.56	-0.18	-0.48	-0.59	-0.71	0.17	-0.62	-0.17	0.15	-0.52		-0.19	-0.55	-0.79	-0.39	-0.56	-0.47	-0.48	-0.53	0.1	-0.33
Non Current Liabilities Total	0.89	0.92	0.8	0.87	0.88	0.89	0.9	0.92	0.87	0.79	0.69	0.87	-0.04	0.81	0.9	-0.19		0.87	0.74	-0.52	0.9	0.92	0.88	0.88	0.75	0.95
Inventory	0.99	0.97	0.65	0.99	0.99	0.99	0.76	0.98	0.99	0.96	0.46	0.98	0.18	0.7	0.98	-0.55	0.87		0.92	-0.42	0.99	0.99	0.97	0.96	0.71	0.94
Other Current Assets	0.94	0.87	0.61	0.94	0.96	0.94	0.7	0.89	0.95	0.98	0.27	0.96	0.16	0.4	0.89	-0.79	0.74	0.92		-0.08	0.94	0.88	0.87	0.92	0.42	0.83
Other Stockholder Equity	-0.38	-0.49	-0.48	-0.38	-0.34	-0.38	-0.42	-0.48	-0.37	-0.17	-0.6	-0.32	-0.08	-0.89	-0.41	-0.39	-0.52	-0.42	-0.08		-0.39	-0.47	-0.52	-0.43	-0.88	-0.47
Total Liab	1.0	0.99	0.71	1.0	0.99	0.99	0.8	0.99	0.99	0.96	0.52	0.99	0.1	0.69	0.99	-0.56	0.9	0.99	0.94	-0.39		0.99	0.97	0.98	0.68	0.94
Total Current Assets	0.99	0.99	0.68	0.98	0.98	0.98	0.79	0.99	0.98	0.93	0.58	0.97	0.07	0.76	1.0	-0.47	0.92	0.99	0.88	-0.47	0.99		0.98	0.96	0.74	0.95
Short Term Debt	0.96	0.99	0.65	0.98	0.95	0.96	0.73	0.99	0.96	0.9	0.58	0.95	0.12	0.75	0.97	-0.48	0.88	0.97	0.87	-0.52	0.97	0.98		0.95	0.73	0.92
Common Stock	0.98	0.96	0.81	0.98	0.98	0.98	0.85	0.96	0.98	0.92	0.55	0.98	0.1	0.71	0.94	-0.53	0.88	0.96	0.92	-0.43	0.98	0.96	0.95		0.68	0.91
Short Term Investments	0.68	0.73	0.63	0.67	0.65	0.68	0.66	0.72	0.68	0.53	0.55	0.64	0.15	0.94	0.69	0.1	0.75	0.71	0.42	-0.88	0.68	0.74	0.73	0.68		0.74
Other Liab	0.94	0.93	0.74	0.93	0.93	0.93	0.84	0.94	0.93	0.88	0.54	0.92	0.1	0.74	0.94	-0.33	0.95	0.94	0.83	-0.47	0.94	0.95	0.92	0.91	0.74

Click cells to compare fundamentals

Valiant Organics Account Relationship Matchups

Valiant Organics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.5B	8.8B	11.8B	12.4B	12.5B	13.1B
Short Long Term Debt Total	1.4B	2.1B	3.6B	2.7B	2.6B	2.7B
Other Current Liab	269.2M	525.6M	199.9M	242.7M	231.9M	138.3M
Total Current Liabilities	1.7B	2.7B	4.0B	3.9B	4.1B	4.3B
Total Stockholder Equity	3.7B	5.0B	6.1B	6.9B	7.3B	7.7B
Property Plant And Equipment Net	4.0B	5.4B	6.4B	7.3B	7.2B	7.5B
Current Deferred Revenue	266.6M	264.1M	173.3M	229.7M	209.9M	109.5M
Net Debt	1.2B	2.0B	3.4B	2.7B	2.5B	2.7B
Retained Earnings	2.5B	3.6B	4.6B	5.4B	5.3B	5.6B
Accounts Payable	878.9M	846.2M	1.3B	1.7B	2.1B	2.2B
Cash	126.5M	128.0M	250.5M	77.5M	34.8M	33.1M
Non Current Assets Total	4.3B	5.7B	6.7B	7.7B	8.4B	8.8B
Cash And Short Term Investments	168.7M	349.5M	499.5M	493.1M	71.0M	67.5M
Net Receivables	1.3B	1.6B	3.2B	2.6B	2.6B	2.7B
Liabilities And Stockholders Equity	6.5B	8.8B	11.8B	12.4B	12.5B	13.1B
Non Current Liabilities Total	990.3M	964.4M	1.3B	1.1B	1.1B	561.6M
Inventory	448.6M	721.7M	1.1B	1.3B	1.1B	1.2B
Other Current Assets	291.5M	393.1M	424.1M	448.5M	820.3M	861.3M
Other Stockholder Equity	1.2B	(4.2B)	(5.3B)	(6.1B)	1.7B	1.8B
Total Liab	2.7B	3.7B	5.4B	5.0B	5.2B	5.4B
Total Current Assets	2.2B	3.0B	5.2B	4.7B	4.1B	4.3B
Short Term Debt	543.6M	1.3B	2.6B	2.0B	1.8B	1.9B
Accumulated Other Comprehensive Income	1.4B	5.4B	6.5B	7.3B	1.7B	2.2B
Short Term Investments	42.2M	221.5M	249.0M	415.6M	36.2M	34.4M
Other Liab	154.5M	151.6M	211.3M	276.6M	318.1M	160.9M
Net Tangible Assets	2.5B	3.8B	4.9B	6.0B	6.9B	7.3B
Other Assets	(3.0)	1K	151.5M	(1K)	1.2K	1.1K
Property Plant Equipment	2.1B	4.0B	5.4B	6.4B	7.4B	7.8B
Long Term Debt	836.7M	753.0M	1.1B	706.1M	741.6M	713.5M
Net Invested Capital	5.1B	6.9B	9.8B	9.6B	9.9B	7.1B
Short Long Term Debt	538.2M	1.1B	2.6B	2.0B	1.8B	1.3B
Net Working Capital	564.1M	319.4M	1.2B	783.4M	(4.4M)	(4.2M)
Intangible Assets	279K	148K	18K	2.1M	2.4M	2.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Valiant Stock Analysis

When running Valiant Organics' price analysis, check to measure Valiant Organics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valiant Organics is operating at the current time. Most of Valiant Organics' value examination focuses on studying past and present price action to predict the probability of Valiant Organics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valiant Organics' price. Additionally, you may evaluate how the addition of Valiant Organics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Valiant Other Liab vs Other Stockholder Equity Analysis

Other Liab vs Other Stockholder Equity

Other Liab vs Other Stockholder Equity Correlation Analysis

Correlation Coefficient

Other Liab

Other Stockholder Equity

Valiant Organics fundamental ratios Correlations

Valiant Organics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Valiant Organics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Valiant Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Total Stockholder Equity	+ 1.0	Total Assets
Property Plant And Equipment Net	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets

Other Stockholder Equity	- 0.89	Cash And Short Term Investments
Short Term Investments	- 0.88	Other Stockholder Equity
Other Current Assets	- 0.79	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.71	Accounts Payable
Common Stock Shares Outstanding	- 0.62	Non Current Assets Total
Other Stockholder Equity	- 0.6	Cash